UK’s largest private hospital operator, Spire Healthcare, has agreed to go into private ownership with a £1.03 billion acquisition by an investor consortium led by Toscafund Asset Management.
Under the Spire Healthcare private takeover deal, shareholders will receive 250p per share, representing a premium of about 66% over Spire’s closing price on May 13, before the takeover discussions became public. The consortium includes funds managed by Toscafund, Three Hills and Ares. Shareholders representing 53.4% of Spire’s stock have already agreed to support the offer.
Spire operates 38 hospitals and more than 55 clinics across England, Wales and Scotland and treated about 1.36 million patients in 2025.
Who Is Behind the Spire Healthcare Acquisition?
The Spire Healthcare acquisition will be carried out through newly formed Tulip UK Bidco, which brings together Toscafund Asset Management, THCP Advisory and Ares Management.
Toscafund was already Spire’s second-largest shareholder and had been in negotiations with the company for several months. The agreement followed a strategic review that involved discussions with more than 60 potential buyers. The Toscafund-led consortium was ultimately the only bidder to submit a formal proposal that Spire’s board considered sufficiently attractive.
The Spire Healthcare Toscafund deal therefore ends a prolonged search for a buyer after earlier discussions with private equity firms Bridgepoint and Triton did not result in an acquisition.
Why Is Spire Healthcare Going Private?
The Spire Healthcare private takeover comes as the company faces higher operating costs and uncertainty in the UK healthcare sector.
Spire has cited pressures including inflation, higher National Insurance contributions and increases in the national minimum wage. Its board also warned that remaining publicly listed could expose the company’s share price to further volatility.
Debbie White, Spire’s chair-designate, said the company had experienced significant volatility and that its board considered the acquisition the “best available outcome” for shareholders.
The buyers argue that private ownership will give Spire greater flexibility to make long-term investments.
Toscafund chief executive Martin Hughes said private ownership would allow the company to move faster while investing in its hospitals, workforce and technology.
Spire Healthcare Private Takeover To Bring Leadership Changes
The Spire Healthcare and Toscafund deal also brings significant leadership changes.
Spire chief executive Justin Ash will step down, while Sir David Sloman, who has led several NHS trusts, will become interim chief executive. Chairman Sir Ian Cheshire will also leave, with former Co-op chair Debbie White becoming interim chair.
These Spire Leadership changes mark a new phase for the company as it moves from the London market to private ownership.
What Could Change After the Spire Healthcare Private Takeover?
The consortium plans to conduct a further year-long strategic review after the Spire Healthcare private takeover. That review could lead to changes in Spire’s primary-care operations, including its private GP network.
Spire also provides workplace health services to more than 1,400 employers. Potential changes to parts of its primary-care business could therefore affect both operations and employment.
For patients and healthcare professionals, the key issue will be whether the new ownership translates its stated investment plans into improvements in hospital infrastructure, technology and patient care.
